Leukemia researchers led by Dr. John Dick have traced the origins of relapse in acute myeloid leukemia (AML) to rare therapy-resistant leukemia stem cells that are already present at diagnosis and before chemotherapy begins.
They have also identified two distinct stem-cell like populations from which relapse can arise in different patients in this aggressive cancer that they previously showed starts in blood stem cells in the bone marrow.
$33 million will drive scientific discoveries into potentially life-saving cures for patients
Government of Canada and partners support five new projects that will help scientists work with industry to address real-world challenges through genomics research
Cultivated sunflowers are one of the five largest oilseed crops in the world and until now sunflower is the last of these crops to have its genome fully sequenced. This genome represents a cornerstone of future work to improve genetic diversity and utilize the sunflower’s stress resistance and ability to grow across different climates.
Researchers and those benefiting their work gather from across Canada on Parliament Hill to illustrate the power of the science to improve health outcomes and strengthen Canada’s bioeconomy.
Genome Canada is pleased to advise the research community of a new funding opportunity – the 2017 Large-Scale Applied Research Project Competition – Genomics and Precision Health.